Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works by Zhao, Hua-fu
Results: 10
1
2
A novel method for predicting cadmium concentration in rice grain using genetic algorithm and back-propagation neural network based on soil properties.
- Published in:
- Environmental Science & Pollution Research, 2018, v. 25, n. 35, p. 35682, doi. 10.1007/s11356-018-3458-0
- By:
- Publication type:
- Article
3
Clinical Applications of and Challenges in Single-Cell Analysis of Circulating Tumor Cells.
- Published in:
- DNA & Cell Biology, 2018, v. 37, n. 2, p. 78, doi. 10.1089/dna.2017.3981
- By:
- Publication type:
- Article
4
Skp2 modulates proliferation, senescence and tumorigenesis of glioma.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1144-z
- By:
- Publication type:
- Article
5
Flesh Shear Force, Cooking Loss, Muscle Antioxidant Status and Relative Expression of Signaling Molecules (Nrf2, Keap1, TOR, and CK2) and Their Target Genes in Young Grass Carp (Ctenopharyngodon idella) Muscle Fed with Graded Levels of Choline.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142915
- By:
- Publication type:
- Article
6
Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
7
Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-020-01728-4
- By:
- Publication type:
- Article
8
Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-020-01728-4
- By:
- Publication type:
- Article
9
Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-020-01728-4
- By:
- Publication type:
- Article
10
Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 175, doi. 10.1007/s10637-018-0684-8
- By:
- Publication type:
- Article